Live Breaking News & Updates on Retinal Program

Stay updated with breaking news from Retinal program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

REGENXBIO Highlights AAV Pipeline with Interim Results from Retinal and Duchenne Programs at its Virtual Investor Day on July 11, 2023

-Interim results from Phase II AAVIATE and ALTITUDE trials of dose level 3 cohorts with short-course prophylactic steroid eye drops resulted in zero cases of. ....

United States , Chris Brinzey , World Muscle Society , Technology Platform , World Muscle Society Congress , Securities Exchange , Exchange Commission , Technology Platform Licensees , Duchenne Program , Retinal Program , American Academy Of Ophthalmology , Manufacturing Innovation Center , Exon Skipping Program , Virtual Investor Day , Investor Day , Chief Executive Officer , Hawaiian Eye , American Academy , Duchenne Muscular Dystrophy , Investigational New Drug , Platform Licensees , Securities Act , Securities Exchange Act , Financial Condition , Regenxbio Inc , Health Care Amp Hospitals ,